Open insulin, 'DIY bio' and the future of pharma

(Colorado State University) The development, manufacture and sale of pharmaceutical drugs in the United States is a complex landscape of intellectual property and federal regulation. The status quo of the US pharmaceutical market may soon be turned on its head. That's due in part to a growing community of do-it-yourself 'biohackers' who are disrupting business-as-usual for pharmaceutical discovery, development and distribution.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news